{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T18:12:42Z","timestamp":1789150362659,"version":"build-2803163510"},"reference-count":65,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"37","funder":[{"DOI":"10.13039\/100009562","name":"Berthold Leibinger Stiftung","doi-asserted-by":"publisher","award":["D12014"],"award-info":[{"award-number":["D12014"]}],"id":[{"id":"10.13039\/100009562","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001646","name":"Robert Bosch Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["EXC 2180 \u2013 390900677"],"award-info":[{"award-number":["EXC 2180 \u2013 390900677"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003542","name":"Ministerium f\u00fcr Wissenschaft, Forschung und Kunst Baden-W\u00fcrttemberg","doi-asserted-by":"publisher","award":["33-7533-6-1522\/2\/3"],"award-info":[{"award-number":["33-7533-6-1522\/2\/3"]}],"id":[{"id":"10.13039\/501100003542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004937","name":"Bundesministerium f\u00fcr Forschung und Technologie","doi-asserted-by":"publisher","award":["BMBF 13N15770"],"award-info":[{"award-number":["BMBF 13N15770"]}],"id":[{"id":"10.13039\/501100004937","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.science.org"],"crossmark-restriction":true},"short-container-title":["Sci. Adv."],"published-print":{"date-parts":[[2026,9,11]]},"abstract":"<jats:p>Within solid tumors, stromal barriers and immune exclusion limit the success of immunotherapies. Thus, novel therapeutic approaches are required to remodel the tumor-supportive microenvironment and enhance therapeutic responses. We developed a bispecific, trivalent Fab-eIg T cell engager (OMTX305) targeting fibroblast activation protein (FAP), a marker of tumor-promoting cancer-associated fibroblasts. The translational potential of OMTX305 was investigated in 2D and 3D patient-derived preclinical models, with a focus on precision-cut tumor slices (PCTSs) of lung and ovarian cancer cocultured with autologous PBMCs. By combining spatial biology with cytokine and transcriptomic analysis, we show that OMTX305 treatment eliminated FAP-expressing fibroblasts, induced interferon responses and extracellular matrix remodeling, ultimately triggering bystander killing of adjacent tumor cells. Distinct immune phenotypes and PD-L1 expression patterns appeared to be associated with differential treatment responses, suggesting their potential as biomarkers for patient stratification. Our findings highlight the clinical potential of targeting stromal elements as a cancer therapy and establish PCTS as a powerful preclinical platform for personalized immunotherapy assessment.<\/jats:p>","DOI":"10.1126\/sciadv.aee2124","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:58:29Z","timestamp":1789149509000},"update-policy":"https:\/\/doi.org\/10.34133\/aaas_crossmark","source":"Crossref","is-referenced-by-count":0,"title":["The FAP \u00d7 CD3 bispecific antibody OMTX305 induces T cell\u2013mediated antitumor effects in patient-derived ex vivo models of solid tumors"],"prefix":"10.1126","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-5437-8498","authenticated-orcid":true,"given":"Julia","family":"Thiel","sequence":"first","affiliation":[{"name":"Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and University of T\u00fcbingen, 70376 Stuttgart, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2916-2368","authenticated-orcid":true,"given":"Jan A.","family":"Schlegel","sequence":"additional","affiliation":[{"name":"Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and University of T\u00fcbingen, 70376 Stuttgart, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0305-2522","authenticated-orcid":true,"given":"Chunguang","family":"Liang","sequence":"additional","affiliation":[{"name":"Institute of Immunology, Jena University Hospital, Friedrich-Schiller-University, 07743 Jena, Germany."},{"name":"Comprehensive Cancer Center Central Germany (CCCCG), Jena University Hospital, 07743 Jena, Germany."},{"name":"Department of Bioinformatics, Biocenter Am Hubland, University of W\u00fcrzburg, 97074 W\u00fcrzburg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8786-8122","authenticated-orcid":true,"given":"Thomas E.","family":"M\u00fcrdter","sequence":"additional","affiliation":[{"name":"Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and University of T\u00fcbingen, 70376 Stuttgart, Germany."},{"name":"Cluster of Excellence iFIT (EXC 2180) \u201cImage-guided and Functionally Instructed Tumor Therapies\u201d, University of T\u00fcbingen, T\u00fcbingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Kneer","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Robert Bosch Hospital, 70376 Stuttgart, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"Dreher","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Robert Bosch Hospital,70376 Stuttgart, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8869-8690","authenticated-orcid":true,"given":"Annelie","family":"Sch\u00e4fer","sequence":"additional","affiliation":[{"name":"Institute of Cell Biology and Immunology, University of Stuttgart, 70569 Stuttgart, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1876-4212","authenticated-orcid":true,"given":"Oliver","family":"Seifert","sequence":"additional","affiliation":[{"name":"Institute of Cell Biology and Immunology, University of Stuttgart, 70569 Stuttgart, Germany."},{"name":"Stuttgart Research Center Systems Biology (SRCSB), University of Stuttgart, 70569 Stuttgart, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6887-8923","authenticated-orcid":true,"given":"Lennart","family":"K\u00fchl","sequence":"additional","affiliation":[{"name":"Institute of Cell Biology and Immunology, University of Stuttgart, 70569 Stuttgart, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Preissler","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Robert Bosch Hospital,70376 Stuttgart, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laureano","family":"Simon","sequence":"additional","affiliation":[{"name":"Oncomatryx Biopharma S.A., Derio 48160, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Fabre","sequence":"additional","affiliation":[{"name":"Oncomatryx Biopharma S.A., Derio 48160, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2583-9052","authenticated-orcid":true,"given":"Isabel","family":"Ega\u00f1a","sequence":"additional","affiliation":[{"name":"Oncomatryx Biopharma S.A., Derio 48160, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1361-8729","authenticated-orcid":true,"given":"Katrin S.","family":"Kurz","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathology, Robert Bosch Hospital, 70376 Stuttgart, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"German","family":"Ott","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathology, Robert Bosch Hospital, 70376 Stuttgart, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7139-1350","authenticated-orcid":true,"given":"Roland E.","family":"Kontermann","sequence":"additional","affiliation":[{"name":"Institute of Cell Biology and Immunology, University of Stuttgart, 70569 Stuttgart, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2165-0187","authenticated-orcid":true,"given":"Walter E.","family":"Aulitzky","sequence":"additional","affiliation":[{"name":"Department of Oncology, Robert Bosch Hospital, 70376 Stuttgart, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9984-075X","authenticated-orcid":true,"given":"Matthias","family":"Schwab","sequence":"additional","affiliation":[{"name":"Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and University of T\u00fcbingen, 70376 Stuttgart, Germany."},{"name":"Cluster of Excellence iFIT (EXC 2180) \u201cImage-guided and Functionally Instructed Tumor Therapies\u201d, University of T\u00fcbingen, T\u00fcbingen, Germany."},{"name":"German Cancer Consortium (DKTK), Partner Site T\u00fcbingen, German Cancer Research Center (DKFZ), Heidelberg, Germany."},{"name":"National Center for Tumor Diseases (NCT), NCT South-West, a partnership between DKFZ, University Hospital T\u00fcbingen, University of T\u00fcbingen, T\u00fcbingen, Bosch Health Campus, Stuttgart, Robert Bosch Hospital, Stuttgart, University Hospital Ulm, and Ulm University, Ulm, Germany."},{"name":"Departments of Clinical Pharmacology, and of Biochemistry and Pharmacy, University T\u00fcbingen, T\u00fcbingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1093-263X","authenticated-orcid":true,"given":"Monilola A.","family":"Olayioye","sequence":"additional","affiliation":[{"name":"Institute of Cell Biology and Immunology, University of Stuttgart, 70569 Stuttgart, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6434-1678","authenticated-orcid":true,"given":"Meng","family":"Dong","sequence":"additional","affiliation":[{"name":"Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and University of T\u00fcbingen, 70376 Stuttgart, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0238-1"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2021.02.028"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07541-6"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-020-09909-3"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20140692"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-024-00896-6"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0028-1"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-0547"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2024.07.002"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK-25-473148"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/immadv\/ltae005"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2023.2183540"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1719076115"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells8070721"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/s44276-025-00159-w"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-008339"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-008185"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1084887"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI96313"},{"key":"e_1_3_2_21_2","unstructured":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft Deutsche Krebshilfe AWMF) Pr\u00e4vention Diagnostik Therapie und Nachsorge des Lungenkarzinoms version 4.0 (Leitlinienprogramm Onkologie Berlin Germany 2025) 020-007OL. [Prevention Diagnosis Treatment and Follow-up Care of Lung Cancer]."},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-21-1714"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2025.03.004"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-23-3252"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ado0173"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.868695"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-024-00740-4"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2014.04.005"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-1484"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-065X.2003.00051.x"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevImmunol.2014009988"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abp9229"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abd1524"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-024-00937-4"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-23-2457"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-021-01692-4"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-022-00503-z"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015956"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109625"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.7150\/jca.26444"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-025-01035-9"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-3431"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aba2325"},{"key":"e_1_3_2_44_2","unstructured":"Boehringer Ingelheim An Open Label Phase I Dose-finding and Expansion Study of BI 765179 as Monotherapy and in Combination With Ezabenlimab (BI 754091) in Patients With Advanced Solid Cancers and BI 765179 in Combination With Pembrolizumab in First-line PD-L1-positive Metastatic or Incurable Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC) (Clinical trial registration NCT04958239 2025); https:\/\/clinicaltrials.gov\/study\/NCT04958239."},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-18-0065"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-0756"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0183390"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1519"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202451589"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-020-0036-4"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04080-z"},{"key":"e_1_3_2_52_2","unstructured":"Oncomatryx Biopharma S.L Phase 1 Dose-escalation Trial of OMTX705 an Anti-fibroblast Activation Protein Antibody-drug Conjugate as Single Agent and in Combination With Anti-PD-1 in Patients With Advanced Solid Tumors\u201d (Clinical trial registration NCT05547321 2025); https:\/\/clinicaltrials.gov\/study\/NCT05547321."},{"key":"e_1_3_2_53_2","unstructured":"Oncomatryx Biopharma S.L. Phase 1b Dose Escalation Trial of OMTX705 an Anti-Fibroblast Activation Protein Antibody-Drug Conjugate in Combination With Gemcitabine\/Nab-Paclitaxel and Tislelizumab in Patients With Advanced\/Metastatic Pancreatic Adenocarcinoma (Clinical trial registration NCT07377045 2026); https:\/\/clinicaltrials.gov\/study\/NCT07377045."},{"key":"e_1_3_2_54_2","unstructured":"Y. Lin Clinical Trial to Evaluate the Antitumor Efficacy and Safety of 177Lu-LNC1004 Injection in Patients With Fibroblast Activating Protein (FAP)-Positive Radioiodine-refractory Differentiated Thyroid Cancer (RAIR-DTC) Who Have Failed TKIs Treatment or Refuse Standard Treatment (Clinical trial registration NCT06898437 2025); https:\/\/clinicaltrials.gov\/study\/NCT06898437."},{"key":"e_1_3_2_55_2","unstructured":"Hoffmann-La Roche An Open-Label Multicenter Phase Ib Study To Evaluate Safety Pharmacokinetics Pharmacodynamics And Preliminary Anti-Tumor Activity Of RO7122290 A Fibroblast Activation Protein-A (FAP) Targeted 4\u20131BB Ligand (CD137L) In Combination With Cibisatamab With Obinutuzumab Pre-Treatment In Participants With Previously Treated Metastatic Microsatellite-stable Colorectal Adenocarcinoma With High CEACAM5 Expression (Clinical trial registration NCT04826003 2025); https:\/\/clinicaltrials.gov\/study\/NCT04826003."},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.medj.2021.08.005"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2022.2063043"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-2238"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells12050807"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.51.36505"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2011.07.009"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1038\/srep17187"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.04.048"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cels.2019.03.003"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1093\/database\/baz046"}],"container-title":["Science Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/sciadv.aee2124","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:58:56Z","timestamp":1789149536000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/sciadv.aee2124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":65,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2026,9,11]]}},"alternative-id":["10.1126\/sciadv.aee2124"],"URL":"https:\/\/doi.org\/10.1126\/sciadv.aee2124","relation":{},"ISSN":["2375-2548"],"issn-type":[{"value":"2375-2548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"assertion":[{"value":"2025-11-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"eaee2124"}}